Mi Bai

机构：University College London · ORCID：0000-0003-1858-2339

发表论文 51 篇 · 总被引 1382 次 · h-index 19

代表论文

• LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease (2023 · EMBO Molecular Medicine · 被引 69)
• Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability (2021 · Clinical Science · 被引 50)
• From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases (2023 · Kidney Diseases · 被引 20)
• Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling (2023 · Clinical Science · 被引 15)
• Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease (2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 13)
• Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling (2024 · Cell Reports · 被引 11)